Absci Corp. (ABSI)
8.45
-0.68
(-7.50%)
USD |
NASDAQ |
Nov 13, 16:00
8.47
+0.02
(+0.24%)
After-Hours: 19:59
Absci Enterprise Value : 1.286B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.286B |
| November 12, 2026 | 1.404B |
| November 11, 2026 | 1.574B |
| November 10, 2026 | 1.548B |
| November 09, 2026 | 1.691B |
| November 06, 2026 | 1.583B |
| November 05, 2026 | 1.448B |
| November 04, 2026 | 1.636B |
| November 03, 2026 | 1.553B |
| November 02, 2026 | 1.500B |
| October 30, 2026 | 1.748B |
| October 29, 2026 | 1.915B |
| October 28, 2026 | 1.877B |
| October 27, 2026 | 1.652B |
| October 26, 2026 | 1.459B |
| October 23, 2026 | 1.412B |
| October 22, 2026 | 1.445B |
| October 21, 2026 | 1.560B |
| October 20, 2026 | 1.393B |
| October 19, 2026 | 1.302B |
| October 16, 2026 | 1.252B |
| October 15, 2026 | 1.360B |
| October 14, 2026 | 1.336B |
| October 13, 2026 | 1.398B |
| October 12, 2026 | 1.496B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.581B |
| October 08, 2026 | 1.371B |
| October 07, 2026 | 1.419B |
| October 06, 2026 | 1.600B |
| October 05, 2026 | 1.817B |
| October 02, 2026 | 1.738B |
| October 01, 2026 | 1.683B |
| September 30, 2026 | 1.686B |
| September 29, 2026 | 1.542B |
| September 28, 2026 | 1.431B |
| September 25, 2026 | 1.474B |
| September 24, 2026 | 1.577B |
| September 23, 2026 | 1.475B |
| September 22, 2026 | 1.640B |
| September 21, 2026 | 1.487B |
| September 18, 2026 | 1.458B |
| September 17, 2026 | 1.393B |
| September 16, 2026 | 1.182B |
| September 15, 2026 | 1.165B |
| September 14, 2026 | 1.191B |
| September 11, 2026 | 1.211B |
| September 10, 2026 | 1.216B |
| September 09, 2026 | 1.287B |
| September 08, 2026 | 1.331B |
| September 04, 2026 | 1.316B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Twist Bioscience Corp. | 6.507B |
| Moderna, Inc. | 89.30B |
| Tenax Therapeutics, Inc. | -39.96M |
| Exicure, Inc. | 5.167M |
| Recursion Pharmaceuticals, Inc. | 1.305B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -33.30M |
| Revenue (Quarterly) | 0.304M |
| Total Expenses (Quarterly) | 33.60M |
| EPS Diluted (Quarterly) | -0.1938 |
| Gross Profit Margin (Quarterly) | -784.2% |
| Profit Margin (Quarterly) | -10.95K% |
| Earnings Yield | -9.40% |
| Normalized Earnings Yield | -9.683 |